News | April 09, 2026
The India FMCG business showed a sequential recovery and is expected to post high-single digit growth
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
Chronic GVHD is a serious and potentially life-threatening condition, imposing profound physical and emotional burdens on a substantial proportion of patients following allogeneic stem cell transplantation
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Subscribe To Our Newsletter & Stay Updated
